MyopiaNCT07229365
Children's Viewing Behavior
A study testing Novel spectacle lens design and Spectacle lenses in people with Myopia and Myopia Progression, run by SightGlass Vision, Inc. at 1 site in United States.
Trial summary
The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed. Read more about this study
- Who is it for?
- Ages 7 to 14 yearsHealthy volunteers can take part
- Conditions the study is for
- Myopia, Myopia Progression, Juvenile Myopia
- What is being tested?
- Novel spectacle lens design and Spectacle lenses
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Dec 2025to 1 Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 14 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- A person is eligible for inclusion in the study if he/she:
- Is 7-14 years of age, inclusive
- Requires spherical spectacle lenses within the power range available for the study lenses
- Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent
- Is willing and able to follow instructions and maintain the appointment schedule
- Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected
- Has had a self-reported oculo-visual examination in the last two years
- Spectacle cylinder of ≤ -0.75DC in both eyes
Who cannot join
- A person will be excluded from the study if he/she:
- Is unable to complete the necessary study activities
- Has any systemic disease affecting ocular health
- Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health
- Is aphakic
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Indiana University
Bloomington, Indiana, 47405
Pete S Kollbaum, OD, PhD
About this study
Official title: Children's Viewing Behavior in Myopia Control Spectacles
The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.
- Conditions
- Myopia, Myopia Progression, Juvenile Myopia
- Being tested
- Novel spectacle lens design, Spectacle lenses
- Medical subject headings
- Myopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Novel spectacle lens designDevice
Use of lenses may reduce the rate of progression of juvenile myopia
Spectacle lensesDevice
Use of lenses may reduce the rate of progression of juvenile myopia
| Study group | Role | What they receive |
|---|---|---|
| SightGlass Vision Test Arm 1 | Experimental | Single vision, impact-resistant spectacle lenses Receives: Device: Novel spectacle lens design |
| SightGlass Vision Test Arm 2 | Experimental | Single vision, impact-resistant spectacle lenses Receives: Device: Spectacle lenses |
What is being measured
The primary outcome is the main question the study is designed to answer.
Activity dependent, gaze location in myopia control spectacles
Measured: 2 months
Subjective/objective quantification of activity via survey or observation
Measured: 2 months
Pupil size
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Nov 2025
- Study start22 Dec 2025
- Primary completion30 Dec 2026 (estimated)
- Study completion1 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MyopiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- SightGlass Vision, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07229365
- Sponsor's protocol ID
- CPRO-2507-002
- Status last verified
- Apr 2026
- First submitted
- 12 Nov 2025
- Last updated
- 30 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 30 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Children's Viewing Behavior in Myopia Control Spectacles
- ClinicalTrials.gov ID
- NCT07229365
- Acronym / sponsor ID
- CPRO-2507-002
- Conditions
- Myopia, Myopia Progression, Juvenile Myopia
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- SightGlass Vision, Inc.Industry (pharma, biotech, devices)
- Study start
- 22 Dec 2025 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 1 Jul 2027 (estimated)
- First posted
- 17 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| SightGlass Vision Test Arm 1 | Experimental | Device: Novel spectacle lens designSingle vision, impact-resistant spectacle lenses |
| SightGlass Vision Test Arm 2 | Experimental | Device: Spectacle lensesSingle vision, impact-resistant spectacle lenses |
Who may qualify
- Ages
- 7 to 14 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (8 listed)
- Is 7-14 years of age, inclusive
- Requires spherical spectacle lenses within the power range available for the study lenses
- Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent
- Is willing and able to follow instructions and maintain the appointment schedule
- Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected
Key exclusion criteria (5 listed)
- Is unable to complete the necessary study activities
- Has any systemic disease affecting ocular health
- Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health
- Is aphakic
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Novel spectacle lens designUse of lenses may reduce the rate of progression of juvenile myopia | Device | SightGlass Vision Test Arm 1 |
| Spectacle lensesUse of lenses may reduce the rate of progression of juvenile myopia | Device | SightGlass Vision Test Arm 2 |
Primary outcome
Activity dependent, gaze location in myopia control spectacles
Time frame: 2 months
Subjective/objective quantification of activity via survey or observation
Time frame: 2 months
Pupil size
Time frame: 2 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Apr 2026.
Related trials for Myopia
RecruitingPhase 3
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
Myopia
Active, not recruitingPhase 4
Odyssey Evaluation in Post LASIK Patients
Cataract
Recruiting
Evaluation of Orthokeratology Lenses With a 5MM Optic Zone Diameter
Myopia, Astigmatism
Recruiting
Wavelength Intervention for Nearsighted Kids
Myopia
Not yet recruiting
SmoothCore Orthokeratology Plus M.O.V.E. Lenses vs. M.O.V.E. Lenses Alone for Myopia Control in Children With High Myopia
High Myopia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Novel spectacle lens design and Spectacle lenses in people with Myopia and Myopia Progression, run by SightGlass Vision, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jennifer Hill (6783614877, jhill@sightglassvision.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Activity dependent, gaze location in myopia control spectacles (time frame: 2 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.